The healthcare industry is undergoing profound transformation, with the evolution of service delivery methods being particularly significant. The widespread adoption of telemedicine and telehealth is a concentrated reflection of this trend. Although the two terms are often used interchangeably, strictly speaking, telemedicine specifically refers to remote clinical services, while telehealth has a broader scope that can include non-clinical services. The impact of the COVID-19 pandemic dramatically accelerated the adoption of these services, transforming them from alternatives into conventional options. This structural shift has attracted numerous investors seeking to profit from the industry’s growth.
Among the many companies operating in this space, some publicly traded ones have distinguished themselves through their unique business models and market positions, becoming the focus of investor attention.
Teladoc Health (TDOC) is a global leader in virtual healthcare. The company provides a wide range of telemedicine and digital health services to over 93 million members, covering areas such as virtual primary care, mental health, and chronic condition management. Its business primarily consists of two segments: the “Integrated Care” segment, which contributes over half of its revenue, and “BetterHelp,” which operates a leading virtual mental health platform. Long-term favorable factors, such as the growing population of chronic disease patients and the shortage of healthcare providers, provide ample room for the company to achieve sustained growth by expanding its products and services.
Doximity (DOCS) is widely regarded as a social networking platform for healthcare professionals, connecting over 80% of physicians in the United States. Its core revenue (approximately 95%) comes from selling marketing subscription services to pharmaceutical companies and healthcare systems. However, telemedicine has become a significant growth driver for the company. Its “Dialer” voice and video product has repeatedly received industry recognition for its excellent performance. Doximity believes its telemedicine business faces a substantial potential market of $43 billion, providing additional momentum for the company’s growth.
CVS Health (CVS), while known for its retail pharmacy, Pharmacy Benefit Management (PBM), and Aetna health insurance businesses, is also a player that cannot be ignored in the telemedicine market. Its MinuteClinic clinics offer virtual consultations for common illnesses and prescription refills, available 24/7. Simultaneously, its Aetna insurance segment partners with companies like Teladoc Health to provide convenient telemedicine services for members and has even launched a virtual primary care plan. While telemedicine is not the primary reason investors focus on CVS Health, its deep involvement in this field is expected to significantly enhance the synergies and customer stickiness of its core insurance and retail businesses.
Overall, telemedicine has evolved from a temporary emergency measure into an indispensable component of the healthcare ecosystem. Teladoc Health, Doximity, and CVS Health are approaching this field from different angles: platform services, integration of professional tools, and empowerment of existing businesses, respectively. Their practices demonstrate that the value of telemedicine lies not only in itself but also in its deep integration with and enhancement of traditional healthcare services, laying a solid foundation for the industry’s long-term development.
